Arizona State Retirement System boosted its position in Hill-Rom Holdings Inc (NYSE:HRC) by 2.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 25,200 shares of the medical technology company’s stock after buying an additional 500 shares during the period. Arizona State Retirement System’s holdings in Hill-Rom Holdings were worth $2,006,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Hill-Rom Holdings by 13,535.4% in the first quarter. BlackRock Inc. now owns 5,067,064 shares of the medical technology company’s stock worth $357,736,000 after buying an additional 5,029,903 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Hill-Rom Holdings by 17.5% in the first quarter. Vanguard Group Inc. now owns 5,737,481 shares of the medical technology company’s stock worth $405,066,000 after buying an additional 853,385 shares during the last quarter. Rothschild Asset Management Inc. purchased a new stake in shares of Hill-Rom Holdings during the first quarter worth approximately $49,880,000. Nationwide Fund Advisors boosted its stake in shares of Hill-Rom Holdings by 135.8% in the first quarter. Nationwide Fund Advisors now owns 387,218 shares of the medical technology company’s stock worth $27,338,000 after buying an additional 223,018 shares during the last quarter. Finally, BTIM Corp. purchased a new stake in shares of Hill-Rom Holdings during the first quarter worth approximately $14,935,000. 84.27% of the stock is currently owned by institutional investors and hedge funds.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 74.07 on Tuesday. The stock’s 50 day moving average price is $78.52 and its 200-day moving average price is $73.59. The stock has a market cap of $4.88 billion, a price-to-earnings ratio of 43.16 and a beta of 1.22. Hill-Rom Holdings Inc has a 12 month low of $50.50 and a 12 month high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The firm had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. During the same quarter in the prior year, the company posted $0.81 earnings per share. Hill-Rom Holdings’s quarterly revenue was up 5.1% on a year-over-year basis. Equities research analysts predict that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.

WARNING: “Arizona State Retirement System Has $2.01 Million Stake in Hill-Rom Holdings Inc (HRC)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/arizona-state-retirement-system-has-2-01-million-stake-in-hill-rom-holdings-inc-hrc/1514788.html.

A number of equities research analysts have recently commented on HRC shares. Barclays PLC raised their price objective on shares of Hill-Rom Holdings from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, May 1st. ValuEngine upgraded Hill-Rom Holdings from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Zacks Investment Research lowered Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Wednesday, May 31st. Morgan Stanley increased their target price on Hill-Rom Holdings from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, June 30th. Finally, Stifel Nicolaus increased their target price on Hill-Rom Holdings from $70.00 to $84.00 and gave the company a “buy” rating in a research report on Monday, May 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $88.17.

In related news, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the transaction, the senior vice president now owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.